Drug Delivery Devices - Netherlands

Netherlands

Highlights

Revenue in the Drug Delivery Devices market market in the Netherlands is anticipated to reach US$384.80m in 2024.
The revenue is forecasted to exhibit an annual growth rate (CAGR 2024-2029) of 5.17%, leading to a market volume of US$495.10m by 2029.
In a global context, the majority of revenue will be produced the United States, which is projected to generate US$15.01bn in 2024.
The Netherlands is witnessing a significant shift towards innovative drug delivery devices, driven by increasing patient-centric healthcare approaches and advanced digital technologies.

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Drug Delivery Devices Market within the Medical Devices sector in the Netherlands is experiencing mild growth, influenced by factors such as an aging population, advancements in technology, and increasing demand for efficient healthcare solutions.

Customer preferences: Consumers in the Netherlands are showing a growing preference for personalized drug delivery devices that cater to individual health needs, reflecting a shift towards more tailored healthcare solutions. This trend is supported by an aging population that values ease of use and convenience in medication management. Additionally, there is an increasing interest in smart devices that integrate with mobile applications, enabling patients to track their medication adherence. The rise of home healthcare solutions is further influencing demand, as consumers seek to manage their health more independently and effectively.

Trends in the market: In the Netherlands, the Drug Delivery Devices Market is experiencing a significant shift towards personalized solutions as consumers increasingly seek devices tailored to their individual health needs. This trend is driven by an aging population that prioritizes user-friendly and convenient medication management options. Furthermore, the integration of smart technology into drug delivery systems is gaining momentum, enabling patients to utilize mobile applications for tracking adherence and health metrics. The rise of home healthcare solutions is reshaping demand, empowering consumers to take control of their health while presenting opportunities for industry stakeholders to innovate and enhance patient engagement and outcomes.

Local special circumstances: In the Netherlands, the Drug Delivery Devices Market is evolving amid a strong emphasis on sustainability and environmental awareness. The country's commitment to green healthcare practices is influencing the development of eco-friendly drug delivery solutions, appealing to health-conscious consumers. Additionally, the Dutch healthcare system's emphasis on patient-centered care fosters innovation in personalized medication management tools. Regulatory frameworks promoting transparency and safety further empower patients, encouraging the adoption of advanced drug delivery technologies that enhance treatment adherence and overall health outcomes.

Underlying macroeconomic factors: The Drug Delivery Devices Market in the Netherlands is shaped by several macroeconomic factors, including robust technological innovation, supportive regulatory frameworks, and healthcare expenditure trends. The country's strong national economy, marked by steady GDP growth and low unemployment, facilitates increased investment in medical technology. Additionally, the Dutch government's focus on sustainability and public health drives funding towards eco-friendly drug delivery solutions. Global trends, such as the rising prevalence of chronic diseases and an aging population, further contribute to the demand for advanced drug delivery devices that improve patient adherence and health outcomes, fostering a dynamic market environment.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.